Release Date: 22/05/13 08:27 Summary: Keysbrook Funding Update Price Sensitive: Yes Download Document 140.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%